Biote (NASDAQ: BTMD), a leading provider of preventive health care through the delivery of personalized hormone therapy, has closed an underwritten public offering of 5,793,500 shares of its Class A common stock by one of its stockholders. According to the update, the shares were sold at a public offering price of $5.35 per share. Biote … Continue reading InvestorNewsBreaks – Biote Corp. (NASDAQ: BTMD) Closes $31M Underwritten Public Offering